Viewing data from:

LIOTHYRONINE SODIUM

ANDA

LIOTHYRONINE SODIUM | A200295 | SIGMAPHARM LABORATORIES LLC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: CYTOMEL(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 11 NDCs

Highest NADAC/Unit

$0.3615

per ea

Lowest NADAC/Unit

$0.2283

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
42794013312LIOMNY 50 MCG TABLET	$0.3615	EA	Generic	—	2026-07-08
42794002012LIOTHYRONINE SOD 50 MCG TAB	$0.3615	EA	Generic	—	2026-06-17
42794002002LIOTHYRONINE SOD 50 MCG TAB	$0.3615	EA	Generic	—	2026-06-17
42794001912LIOTHYRONINE SOD 25 MCG TAB	$0.3191	EA	Generic	—	2026-06-17
42794001902LIOTHYRONINE SOD 25 MCG TAB	$0.3191	EA	Generic	—	2026-06-17
42794001906LIOTHYRONINE SOD 25 MCG TAB	$0.3191	EA	Generic	—	2026-06-17

Showing 6 of 11 NDCs.

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain4 active DMFs1 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

PEPTIDO GMBHLIOTHYRONINE SODIUM

DMF 194672006

AZICO BIOPHORE INDIA PVT LTDLIOTHYRONINE SODIUM

DMF 309422016

VALARY LAB PRIVATE LIMITEDLIOTHYRONINE SODIUM

DMF 389032023

MACLEODS PHARMACEUTICALS LTDLIOTHYRONINE SODIUM USP

DMF 424012025

SANDOZ GMBHInactiveLIOTHYRONINE SODIUM

DMF 71101987

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — EQ 0.005MG BASE

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Nov 29, 2012

No patent or exclusivity listings for this strength.

#002 — EQ 0.025MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 29, 2012

#003 — EQ 0.05MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 29, 2012